Retour
36
Fourchette du Jour
21,17 €
22,19 €
Fourchette 52 Semaines
19,94 €
41,73 €
Volume
1 136 538
Moyenne 50J / 200J
30,65 €
/
31,45 €
Clôture Précédente
21,31 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -18,1 | 0,2 |
| P/B | 0,6 | 3,0 |
| ROE % | -3,2 | 3,6 |
| Net Margin % | -9,4 | 3,8 |
| Rev Growth 5Y % | 3,7 | 9,9 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
43,00 €
+96.7%
Low: 38,00 €
High: 45,00 €
P/E Prévisionnel
27,74
BPA Prévisionnel
0,79 €
Croissance BPA (est.)
+0,0%
CA Est.
620,12M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,76 €
1,73 € – 1,80 €
|
742,80M | 1 |
| FY2029 |
1,30 €
1,28 € – 1,33 €
|
683,50M | 1 |
| FY2028 |
1,29 €
1,05 € – 1,47 €
|
699,62M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | 0,14 € | 0,09 € | -34,8% |
| 2025-11-21 | 0,19 € | 0,21 € | +10,8% |
| 2025-08-05 | 0,13 € | 0,19 € | +46,2% |
| 2025-05-07 | 0,09 € | 0,05 € | -44,4% |
| 2025-02-05 | 0,05 € | 0,08 € | +60,0% |
| 2024-11-12 | 0,11 € | 0,18 € | +63,6% |
| 2024-08-06 | 0,07 € | 0,16 € | +128,6% |
| 2024-05-08 | 0,02 € | 0,05 € | +167,8% |
Dividend History
3 yr streakYield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 02, 2021 | Dec 23, 2021 | 0,10 € | 0,37% |
| Sep 02, 2021 | Sep 24, 2021 | 0,10 € | 0,47% |
| Jun 03, 2021 | Jun 25, 2021 | 0,10 € | 0,41% |
| Mar 04, 2021 | Mar 26, 2021 | 0,10 € | 0,52% |
| Dec 03, 2020 | Dec 17, 2020 | 0,10 € | 0,56% |
| Sep 03, 2020 | Sep 25, 2020 | 0,10 € | 0,82% |
| Jun 04, 2020 | Jun 26, 2020 | 0,10 € | 0,93% |
| Mar 05, 2020 | Mar 27, 2020 | 0,10 € | 1,15% |
| Dec 05, 2019 | Dec 20, 2019 | 0,10 € | 0,98% |
| Sep 05, 2019 | Sep 27, 2019 | 0,10 € | 1,14% |
| Jun 06, 2019 | Jun 28, 2019 | 0,10 € | 1,00% |
| Feb 28, 2019 | Mar 22, 2019 | 0,10 € | 1,25% |
| Dec 06, 2018 | Dec 20, 2018 | 0,10 € | 1,45% |
| Sep 06, 2018 | Sep 28, 2018 | 0,10 € | 1,10% |
| May 31, 2018 | Jun 22, 2018 | 0,10 € | 1,22% |
| Mar 01, 2018 | Mar 23, 2018 | 0,10 € | 1,51% |
| Nov 30, 2017 | Dec 22, 2017 | 0,10 € | 1,61% |
| Sep 07, 2017 | Sep 29, 2017 | 0,10 € | 1,47% |
| May 31, 2017 | Jun 23, 2017 | 0,10 € | 1,45% |
| Mar 01, 2017 | Mar 24, 2017 | 0,10 € | 1,88% |
Points Clés
Revenue grew 3,69% annually over 5 years — modest growth
Debt/Equity of 0,06 — conservative balance sheet
Generating 38,32M in free cash flow
PEG of 0,39 suggests growth is underpriced
Capital efficient — spends only 5,70% of revenue on capex
Croissance
Revenue Growth (5Y)
3,69%
Revenue (1Y)3,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-3,19%
ROIC-0,46%
Net Margin-9,39%
Op. Margin-1,90%
Sécurité
Debt / Equity
0,06
Current Ratio2,98
Interest Coverage0,00
Valorisation
P/E Ratio
-18,06
Forward P/E27,74
P/B Ratio0,58
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,55% | Revenue Growth (3Y) | -5,51% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,69% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 593,82M | Net Income (TTM) | -55,76M |
| ROE | -3,19% | ROA | -2,71% |
| Gross Margin | 45,52% | Operating Margin | -1,90% |
| Net Margin | -9,39% | Free Cash Flow (TTM) | 38,32M |
| ROIC | -0,46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 2,98 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 3 yrs | ||
| Valuation | |||
| P/E Ratio | -18,06 | Forward P/E | 27,74 |
| P/B Ratio | 0,58 | P/S Ratio | 1,70 |
| PEG Ratio | 0,39 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 7,72 |
| Forward P/S | 1,62 | Fwd Earnings Yield | 3,60% |
| FCF Yield | 3,81% | ||
| Market Cap | 1,01B | Enterprise Value | 838,29M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593,82M | 573,45M | 665,07M | 555,50M | 513,70M |
| Net Income | -55,76M | -164,90M | -14,26M | -428,96M | 110,75M |
| EPS (Diluted) | -1,22 | -3,09 | -0,22 | -0,15 | -0,39 |
| Gross Profit | 270,28M | 254,62M | 233,26M | 230,62M | 214,51M |
| Operating Income | -11,27M | -29,98M | -82,20M | -24,02M | 3,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,06B | 2,10B | 2,89B | 3,72B | 1,82B |
| Total Liabilities | 330,70M | 331,07M | 351,22M | 352,74M | 494,18M |
| Shareholders' Equity | 1,73B | 1,77B | 2,53B | 3,36B | 1,33B |
| Total Debt | 111,17M | 70,68M | 60,44M | 49,23M | 94,77M |
| Cash & Equivalents | 279,78M | 310,93M | 678,91M | 658,27M | 227,43M |
| Current Assets | 708,34M | 832,81M | 1,42B | 2,46B | 777,37M |
| Current Liabilities | 237,67M | 204,84M | 210,93M | 230,55M | 345,09M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#505 of 826
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026